Intensity Therapeutics, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
INTS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1 Enterprise Drive, Suite 430, Shelton, CT

There are no Buy or Sell transactions made by insiders since 12/23/2023

Intensity Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lewis H. Bender President and CEO, Director, 10%+ Owner $8M Mar 6, 2024
John M. Wesolowski Principal Accounting Officer $26.8K Oct 21, 2024
James M. Ahlers Executive VP of CF Jun 29, 2023
Joseph Talamo Chief Financial Officer Oct 21, 2024
Emer Leahy Director Mar 6, 2024
I. Dubin Thomas Director May 14, 2024
Mark A. Goldberg Director Mar 6, 2024
Daniel Donovan Director Mar 6, 2024

Recent Insider Transactions by Companies or Individuals for Intensity Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.